President Trump signs executive order directing FDA to support research that could lead to approval of psychedelic drugs

President Trump signs an executive order directing the Food and Drug Administration to support research on psychedelic drugs and potentially move toward approval. The signing takes place at the White House alongside high-profile figures including podcaster Joe Rogan, Health and Human Services Secretary Robert F. Kennedy, Jr., and NIH Director Dr. Jay Bhattacharya. Trump frames the effort as a way to help Americans dealing with mental illness, and he expresses hopes for FDA action this summer. The report notes that common psychedelics include psilocybin, LSD, and ibogaine, and that these substances are currently illegal under federal law.